...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: AHA late breaking abstract

"Has RVX applied a patent to protect this discovery in relation to ABET in the targeted patient population?"

An alkaline phosphatase related patent could be the one DM was referring to in the webcast.

BDAZ

Share
New Message
Please login to post a reply